Omeprazole is safe to use during breastfeeding
Omeprazole can be used while breastfeeding, as only minimal amounts transfer into breast milk and no adverse effects on breastfed infants have been documented. The FDA drug label states that "limited data suggest omeprazole may be present in human milk" but emphasizes that "the developmental and health benefits of breastfeeding should be considered along with the mother's clinical need for omeprazole" 1.
Evidence Supporting Safety
The strongest clinical evidence comes from a case study demonstrating that peak omeprazole concentrations in breast milk (58 nM at 3 hours post-ingestion) were less than 7% of the peak maternal serum concentration (950 nM at 4 hours), indicating minimal secretion into breast milk 2. This extremely low transfer rate means the infant receives negligible exposure.
The key pharmacologic principle here is that omeprazole's poor oral bioavailability in infants further reduces any theoretical risk - even the small amount present in breast milk would be poorly absorbed by the infant's gastrointestinal tract.
Clinical Approach
- No interruption of breastfeeding is required when taking omeprazole
- No "pump and dump" period is necessary
- Standard therapeutic doses (20-40 mg daily) are acceptable
- The mother can continue breastfeeding on her normal schedule
Important Caveats
While omeprazole itself is compatible with breastfeeding, be aware that:
- The underlying maternal condition requiring treatment should be appropriately managed
- If the mother requires multiple medications, evaluate each drug individually for lactation safety
- Monitor the infant for any unusual symptoms (though none have been reported with omeprazole exposure through breast milk)
The evidence consistently supports that omeprazole poses minimal to no risk to breastfed infants, making it an appropriate choice for treating acid-related disorders in lactating mothers 1, 2, 3.